Tags : Early Summer

Regeneron to Initiate COVID-19 Antibody Program in Early Summer

Shots: Regeneron advances its program to discover and develop a novel multi-Ab cocktail, administered as prophylaxis before exposure to the SARS-CoV-2 virus or as a treatment for already infected patients The company plans to initiate the clinical studies by early summer and has isolated mAb from its VelocImmune mice and from humans who have recovered […]Read More